Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.

Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for two types of ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...

Eli Lilly announced preliminary fourth-quarter revenue of roughly $13.5 billion, or $400 million below the low end of its guidance, driven by slower-than-expected US market growth and lower ...

The US financial regulator is reportedly suing Tesla CEO Elon Musk, claiming that the billionaire did not properly disclose his growing stake in the social media platform formerly known as Twitter.

The tweet gained over 7,000 retweets and 58,000 likes (shown below, left). On July 6th, user @KWholesaler [4] posted a parody that gained over 13,000 retweets and 50,000 likes (shown below, right).

Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations. Eli Lilly expects about $3.5 billion in revenue for its diabetes ...

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue ...

CNBC’s Jim Cramer delivers his daily Mad Dash. You stay, you pay: Starbucks reverses open-door policy Where Are Michelin Tires Made And Who Owns The Brand? Biden’s best foreign policy decision ...